NYSE: TEVA - Teva Pharmaceutical Industries

Yield per half year: +30.05%
Dividend yield: 0.00%
Sector: Healthcare

Current price
20.94 $
Average price
13.13 $ -37.29%

Price based on EPS
18.34 $ -12.43%
Price according to DCF model (FCF)
20.12 $ -3.9%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 18.34 $
Current price = 20.94 $ (difference = -12.43%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 0.9328 $
Current price = 20.94 $ (difference = -95.55%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 20.12 $
Current price = 20.94 $ (difference = -3.9%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription